A Repeat-dose Study in Subjects With Type 2 Diabetes Mellitus to Assess the Efficacy, Safety, Tolerability and Pharmacodynamics, of Albiglutide Liquid Drug Product
Phase of Trial: Phase III
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Albiglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 07 Jun 2017 Status changed from active, no longer recruiting to completed.
- 14 Sep 2016 Status changed from recruiting to active, no longer recruiting.